आऋऑऎऊࣽईࣜऋंࣜ उँऀअࣿࣽईࣜ ࣿऋईईँःँएࣜऋंࣜऌईࣽ Journal of Medical Colleges of PLA 23 (2008) 276–282
www.elsevier.com/locate/jmcpla
Relationship between autonomic nervous system function and acute mountain sickness Long Min1, Huang Lan2, Tian Kaixin2, Yu Shiyong2, Yu Yang2, Qin Jun2* 1
Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China 2 Cardiovascular Diseases Research Center, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China Received 4 March 2008, accepted 24 May 2008
Abstract Objective: To elucidate the role of the autonomic nervous system (ANS) in acute mountain sickness (AMS) during the initial phase at acute high-altitude exposure. Methods: Ninety-nine healthy sea-level residents rapidly ascended to Tibet plateau (3 675 m altitude) by airplane from Chengdu plain (560 m altitude). ANS function was tested in plain and day 2–4 in Tibet by heart rate variability (HRV), cold pressor test (CPT). AMS was evaluated by clinic symptomatic scores. All subjects were divided into non-AMS group (57, scores4) and AMS group (42, scores>4). Results: Compared with non-AMS group, AMS group had higher standard deviation of normal to normal intervals (SDNN), root mean square of delta RR (rMSSD), low-frequency (LF) power, and normalized low-frequency (LFnu) power in plain (P<0.05). After arrival at 3 675 m altitude, AMS group had greater reduction in percentage of delta RR>50 ms(PNN50 ), rMSSD (P<0.01) and SDNN, LF, total power (TP) (P<0.05). Although no significant differences in the increase of SP and DP during CPT were found between 2 groups in plain, the SP increase during CPT of AMS group was less than non-AMS group (P<0.05) at 3 675 m altitude. AMS symptomatic scores was not only positively correlated with SDNN, rMSSD, LF/HF in plain (P<0.05), but also negatively correlated with HFnu in plain (P<0.05). Conclusion: During the initial high altitude exposure, ANS modulation is generally blunted, but the relatively predominant sympathetic control is enhanced, and this characteristic change of ANS function is positively correlated with the development of AMS. Keywords: High altitude; Autonomic nervous system; Acute mountain sickness; Heart rate variability; Cold pressor test
* Corresponding author. Tel.: 86-23-68774625 E-mail address:
[email protected] (Qin J.)
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
277
plateau within 90 min. AMS symptomatic scores
1. Introduction
were elevated according to principles of diagnosis and treatment of benign form of acute mountain
Acute mountain sickness (AMS) refers to a
sickness [9] on day 1 in Tibet plateau. Fifty-seven
series of acute reactions in people who acutely
subjects whose scores were 4 or less were divided
ascend from near sea level to altitude higher than
into non-AMS group, while the other 42 subjects
3 000 m [1, 2].Several studies had indicated the
whose scores were higher than 4 were divided into
change
parasympathetic
AMS group. Throughout the study, temperature
activity during high-altitude exposure [3–5]. At
was kept constant at 14–20 ć . Subjects were
high altitude people with high AMS scores
banned to drink coffee or take any medicine.
demonstrated more active sympathetic activity than
Before each measurement, a 15-minute rest was
those with low AMS scores in some degree [6], and
necessary.
of
sympathetic
and
autonomic cardiovascular dysfunction accompanied AMS [7], our experimental study have found
2.2. Observation indexes
high AMS scores people had more obvious decrease of sympathetic and parasympathetic activity [8]. So, we hypothesize that there should be more profound relation between ANS function change and AMS after exposure to plateau field. By means of such techniques as heart rate variability (HRV) measurements and cold pressor test (CPT) to evaluate ANS function, we attempt to compare ANS function of AMS group with that of non-AMS group, reveal the relationship between ANS function change and AMS attack, and provide practical evidences to AMS pathogenesis.
2. Subjects and methods 2.1. Subjects and procedure Ninety nine healthy sea-level male residents (age 19.2±0.96, height 167.00±3.33 cm, and body weight 59.16±5.63 kg) were enrolled in this study. Records were obtained at 560 m altitude (Chengdu plain, Sichuan provinceˈChina) and on day 2–4 at 3 675 m altitude (Tibet plateau, Tibet autonomous region, China) respectively. On the day following the completion of measurement in plain, all subjects were transported by airplane to the Tibet
2.2.1. Heart rate variability (HRV) Analysis of heart rate variability (HRV) is an effective, noninvasive method of assessing the cardiocirculatory system control, by respectively analyzing sympathetic and parasympathetic components of the autonomic nervous system. Five-minute R-R intervals were recorded (Model D/SF-I, Dikang Medical Digital Instrument Co. Ltd, Chengdu, China) in this study. Owing to technique failure, 13 subjects HRV initial data were lost. 86 subjects was measured the short-term HRV respectively in Chengdu plain and on day 2–4 in Tibet plateau successfully in a supine position. Time domain, frequency and non-linear parameters were analyzed by special software. SDNN, one important time domain index, is standard deviation of normal to normal intervals and reflects all the cyclic components responsible for variability in the period of recording. Root mean square of delta RR (rMSSD) and percentage of delta RR>50 ms (PNN 50) were closely related to parasympathetic activity. Power spectrum was obtained by an autoregressive modeling technique. The total power (TP) (0.03–0.40 Hz) is used to estimate of overall autonomic nervous activity. Disagreement
278
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
exists in respect to the Low-frequency (LF) power (0.04–0.15 Hz), most of studies view LF power as
2.3. Evaluation of AMS
reflecting both sympathetic activity and parasympathetic activity. High-frequency (HF) power
Clinical questionnaires were made according
(0.15–0.40 Hz) is regarded as a marker of
to principles of diagnosis and treatment of benign
parasympathetic activity. The representation of LF
form of acute mountain sickness GJB1098-91 [9]
and HF in normalized units (LFnu= LF/[TPíVLF]
and were distributed to all the subjects. Subjects
×100%, HFnu=HF/[TPíVLF]×100%) emphasizes
recorded symptoms in the first evening in Tibet
the controlled and balanced behavior of the two
plateau.
branches of the autonomic nervous system. The LF-to-HF ratio (LF/HF) is considered by some
2.4. Statistical analysis
investigators to mirror sympathovagal balance or to reflect the sympathetic modulations. Fractal dimension (FD), the only non-linear parameter in this study, reflects complex physiological meaning and related to autonomic and central nervous regulations [10].
2.2.2. Cold pressor test (CPT) Because of severe complaints during test and technique failure, 72 subjects’ CPT was successfully performed in Chengdu plain and on day 2 in Tibet plateau respectively. Resting blood pressure was measured in the right upper arm with an electrocardiogram monitor (MP-900F, Nanning Sanqiu Commerce Trade Co, Ltd, China). The left hand below the wrist was immersed in cold water (3 to 5 ć ) for 2 min; blood pressure measurements were obtained at 30, 120, and 300 s after immersion. 2.2.3. Resting blood pressure (BP) and heart rate (HR) All 99 subjects’ resting systolic pressure (SP), diastolic pressure (DP) at the right brachial artery and heart rate (HR) were measured by electrocardiogram monitor (MP-900F, Nanning Sanqiu Commerce Trade Co, Ltd, China) in early morning, in Chengdu plain and on day 2 in Tibet plateau.
Data were analyzed with SPSS10.0 statistical package. Results were expressed as mean±SD. Probabilities of significant differences between high AMS and non-AMS subject groups were obtained by student’s t tests. Differences in the response of each group from plain to Tibet were analyzed
by
paired
sample
tests.
Pearson’s
correlation coefficients were used to determine relationships between AMS score and other variables. A P value of <0.05 was taken as evidence of significance.
3. Results AMS group was significantly higher than non-AMS group in terms of SDNN, rMSSD and LF (P<0.05) in plain, but HFnu was the opposite (P<0.05). After acute exposure to Tibet plateau, no significant differences between the 2 groups were found in HRV parameters (Table 1). But, AMS group displayed a much higher decrease in rMSSD and
PNN 50 [46.15±76.41
vs
2.64±47.88
ms,
(10.77±11.58)% vs (3.91±9.59)%, P<0.01] compared with non-AMS group; SDNN, LF and TP in AMS
group
decreased
significantly,
too
(33.17±55.41 vs 3.77± 32.23 ms, 107.26±198.52 vs 8.98±84.36 ms 2, 317.74± 655.29 vs 46.42±257.77 ms 2, P<0.05).
279
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
Table 1 Comparison of HRV in non-AMS and AMS group in plain and Tibet plateau (mean±SD) non-AMS group
AMS group
(n=49)
(n=37)
1.95±1.19
7.17±2.85 b
í9.307
0.000
SDNN (ms)
54.61±17.16
74.68±49.75
í2.088
0.045
rMSSD (ms)
57.90±24.57
88.32±71.41
í2.206
0.035
Parameters AMS score
PNN 50 (%)
t
P
14.38±9.11
17.25±9.86
í1.262
0.211
2
122.11±77.50
205.12±190.01
í2.228
0.032
2
LF power (ms ) Chengdu plain
HF power (ms )
168.72±115.25
259.80±321.92
í1.460
0.154
HRV
2
TP (ms )
415.75±220.40
615.79±568.08
í1.805
0.080
LFnu (%)
41.53±11.35
44.31±12.44
í0.976
0.332
HFnu (%)
54.91±12.17
47.59±12.44
2.467
0.016
LF/HF
0.85±0.44
1.04±0.60
í1.600
0.114
FD
7.17±1.07
6.59±1.70
1.636
0.109
SDNN (ms)
50.84±28.95
41.51±25.71
1.396
0.167
rMSSD (ms)
55.26±43.40
42.17±38.30
1.309
0.195
PNN 50 (%)
10.47±9.35
6.48±7.29
1.927
0.058
2
113.132±78.38
97.86±75.25
0.820
0.415
2
LF power (ms ) Tibet plateau
HF power (ms )
109.95±102.04
82.50±75.80
1.232
0.222
HRV
2
TP (ms )
369.32±227.47
298.06±277.02
1.187
0.239
LFnu (%)
48.81±17.49
51.76±13.46
í0.765
0.447
HFnu (%)
45.07±16.03
42.54±12.97
0.705
0.483
LF/HF
1.44±1.23
1.42±0.75
0.078
0.938
FD
5.96±1.37
5.68±2.03
0.689
0.493
AMS: acute mountain sickness; HRV: heart rate variability; rMSSD: root mean square of delta RR; PNN50 : percentage of delta RR>50 ms; LF: low-frequency; HF: high-frequency; TP: tota power; LFnu: LF/(TPíVLF)h100%; HFnu: HF/(TPíVLF)h100%; FD: fractal dimension.
In plain, no significant differences in the increase of SP and DP during CPT were found between AMS and non-AMS groups. But at acute exposure to Tibet plateau, the increase in SP during CPT was much less pronounced in AMS group than in non-AMS group (8.44±6.53 vs 12.93±9.46 mmHg, P<0.05). However, no significant differrences were found in the increase of DP in the 2 groups. Compared with baseline, non-AMS group
displayed imperceptible change in the increase of both SP (16.61±11.33 vs 12.93±9.46 mmHg, P>0.05) and DP (13.66±9.16 vs 9.97±7.28 mmHg, P>0.05) during CPT. However, AMS group displayed a more pronounced decrease in the increase of SP during CPT at acute exposure to Tibet plateau (17.56±10.59 vs 8.44±6.53 mmHg, P<0.01), but no significant change was found in DP (12.67 ±8.25 vs 9.74±5.42 mmHg, P>0.05).
280
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
No marked difference between AMS group
suggested AMS group had the lower percentage of
and non-AMS group was found for resting HR and
parasympathetic
BP in plain or Tibet. Compared with baseline, a
Therefore compared with non-AMS group, AMS
marked increase in resting HR was found in non-
group displayed stronger sympathetic activity,
AMS and AMS groups at acute exposure to Tibet
parasympathetic and overall ANS activities as well
plateau (74.55±10.40 vs 96.74±14.95 times/min,
as lower percentage of parasympathetic activity in
75.83±14.50 vs 95.97±11.44 times/min, P<0.01),
ANS activity in plain.
activity
in
ANS
activity.
however, the resting BP change was not significant.
In acute exposure study of 11 subjects to a
There was a marked positive correlation
simulated altitude of 5 000 m by inspiring a
between AMS score and SDNN, rMSSD and
gaseous mixture containing 10.5ˁ oxygen for 30
LF/HF ratio measured in plain (r=0.245, 0.268,
min, those subjects with marked decrease of
0.299; P<0.05). A pronounced negative correlation
rMSSD and significant increase of LFnu and
was found between AMS scores and HFnu
LF/HF demonstrated poor tolerance of hypoxia
measured in plain (r=í0.387, P<0.01). There was
[11]. In a recent study [12] rats were acutely
also a marked positive correlation between AMS
exposed to an altitude of 4 000 m. Those rats
score and the change in rMSSD and SDNN after
preacclimatized to hypobaric hypoxia in a steel
acute exposure to Tibet plateau (r=0.234, 0.255,
chamber (Po 2-100 torr, 4 000 m simulated) for 70 d
P<0.05).
found
changed less in LF, HF and TP after 30 min at an
between AMS score and change in BP during CPT.
altitude of 4 000 m, which suggested stronger ANS
Marked
correlation
was not
modulation in rats have less HRV variation. In the
4. Discussion
same, continual measurement of many HRV parameters in the present study demonstrated a
Our previous study has reported the changes
much higher decrease in rMSSD, PNN50, SDNN,
of ANS function during the initial phase of acute
LF and TP in AMS group at acute high-altitude
exposure to Tibet plateau [3]. The changes include
exposure and less change in BP of AMS group
a transient reduction in sympathetic and para-
during CPT conducted in plateau compared with
sympathetic activities, predominant sympathetic
non-AMS group. Therefore comparison between
control, and generally blunted ANS modulation,
groups showed that people with weak ANS
followed by the slow recovery of ANS function. At
modulation were more predisposed to AMS.
present, it is accepted that people with stronger
In our study, no significant differences
sympathetic activity is riskier at acute high-altitude
between AMS group and non-AMS group were
exposure [6–7].
found for HRV, resting HR and BP on day 2–4 in
The present study revealed that in plain LFnu
Tibet plateau. We didn’t deny if ANS function of
and LF/HF of AMS group were slightly higher than
all subjects everyday was measured on day 1–4 in
those of non-AMS group while LF, rMSSD and
Tibet plateau, marked differences in ANS function
SDNN of AMS group were significant higher.
is found between AMS group and non-AMS group.
These suggested compared with non-AMS group,
Moreover, we supposed ANS change on day 1 in
AMS group may be stronger sympathetic activity
Tibet plateau might be more significant than the
and parasympathetic activity. In addition, the HFnu
following days. Another deficiency of the study
comparison between AMS and non-AMS group
was that it was impossible to exclude subjective
281
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
interference
completely
when
such
clinical
are
predisposed
to
severe
AMS.
HRV
symptoms as headache, vomit, dizziness, etc were
measurements may help predict people susceptible
used to score AMS.
to AMS and screen people who are not predisposed
Up to now, few studies on the correlation
to AMS.
between ANS change and AMS score has been reported. A study showed that after simulated acute
References
high-altitude exposure for 6 h or 12 h plasma catecholamine of AMS group was significantly
1. Savourey G, Guinet A, Besnard Y,et al. Valuation of
higher than that of non-AMS group [6]. The
the Lake Louise acute mountain sickness scoring
present study revealed the correlation between
system in a hypobaric chamber. Aviat Space Environ
AMS score on day 1 in Tibet and HRV parameters
Med 1995; 66 (10): 963–967.
LF/HF, rMSSD, SDNN and HFnu measured in plain. Specifically, AMS score on day 1 in Tibet
2. Basnyat B.The physiologic basis of high altitude diseases. Ann Intern Med 2004; 141 (10): 789–800.
was not only positively correlated with pre-
3. Long M, Qin J, Huang L, et al. Change of autonomic
dominant sympathetic control (LF/HF), para-
nervous system function at the early stage of rapid
sympathetic activity (rMSSD) and overall ANS
entering Tibet plateau. Zhonghua Hang Kong Hang
activities (SDNN), but also negatively correlated
Tian Yi Xue Za Zhi 2006;17(3): 196–199. (In
with relative parasympathetic activity (HFnu), too.
Chinese)
This finding suggested that in plain people with stronger
sympathetic
and
4. Sevre K, Bendz B, Hanko E, et al. Reduced
parasympathetic
autonomic activity during stepwise exposure to high
activities and relatively predominant sympathetic
altitude. Acta Physiol Scand 2001; 173 (4): 409
control would have severe AMS symptoms at acute
–417.
high-altitude exposure. Moreover, the present
5. Cornolo J, Mollard P, Brugniaux JV, et al. Auto-
study also demonstrated the positive correlation
nomic control of the cardiovascular system during
between AMS score and change of rMSSD and
acclimatization to high altitude: effects of sildenafil.
SDNN during acute high-altitude exposure, that
J Appl Physiol 2004; 97 (3): 935–940.
suggested that people with weak ANS modulation
6. Loeppky J.A,Icenogle M.V,Maes D,et al. Body
would have severe AMS symptoms. With reference
temperature,
to the regularity of ANS change before and after
mountain sickness. High Alt Med Biol 2003; 4(3):
acute high-altitude exposure, it can be inferred that
367–373.
autonomic
responses,
and
acute
ANS may play an important role in AMS attack.
7. Lanfranchi PA, Colombo R, Cremona G, et al.
Significant correlation between AMS score and BP
Autonomic cardiovascular regulation in subjects
change during CPT was not found in the present
with acute mountain sickness. Am J Physiol Heart
study. For more factors may interfere with the
Circ Physiol 2005; 289 (6): H2364–H2372.
measurement of ANS function during CPT [13].
8. Long M, Qin J, Huang L, et al. The role of
Briefly, ANS function is related to AMS
autonomic nerve system in the pathogenesis of acute
attack and the severity of the symptoms. In plain
mountain sickness. Jiefangjun Yi Xue Za Zhi 2007;
people
32 (4): 405–408. (In Chinese)
with
strong
sympathetic
and
para-
sympathetic activities and relatively predominant
9. Yin ZY, Xie YZ, Niu WZ, et al. Principles of
sympathetic control and/or weak ANS modulation
diagnosis and treatment of benign form of acute
282
Long Min et al. / Journal of Medical Colleges of PLA 23 (2008) 276–282
mountain sickness. Jiefangjun Yu Fang Yi Xue Za
Hang Tian Yi Xue Yu Yi Xue Gong Cheng 2001; 14
Zhi 1997; 15 (6): 395–399. (In Chinese)
(5): 328–331. (In Chinese)
10. Task Force of the European Society of Cardiology
12. Melin A, Fauchier L, Dubuis E, et al. Heart rate
the North American Society of Pacing Electro-
variability in rats acclimatized to high altitude. High
physiology. Heart Rate Variability Standards of
Alt Med Biol 2003; 4 (3): 375–387.
Measurement,
Physiological
Interpretation,
and
Clinical Use. Circulation 1996; 93 (5): 1043–1065. 11. Liu XX, Lu LL, Zhong CF, et al. Analysis of heart
13. Mitchell LA, MacDonald RA, Brodie EE, et al. Temperature and the cold pressor test. J Pain 2004; 5 (4): 233–237.
rate variability during acute exposure to hypoxia.
(Editor Guo Jianxiu)